Vasopressin receptor antagonists and products and methods related thereto

Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, iso...

Full description

Saved in:
Bibliographic Details
Main Authors Urbano, Mariangela, Tierney, Jason, Jones, Robert M, Hardick, David, Knight, Chris, Chambers, Mark, Lock, Chris, Brandt, Gary
Format Patent
LanguageEnglish
Published 21.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds are provided that antagonize vasopressin receptors, particularly the V1a receptor products containing such compounds, as well as to methods of their use and synthesis. Such compounds have the structure of Formula (I), or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof:wherein Q1, Q2, Q3, R2a, R2b, R3 and X are as defined herein.
Bibliography:Application Number: US201816122780